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Abstract. We used quantitative reverse transcription 
(RT)/PCR to study the regulation of p75 mRNA and 
trkA mRNA expression in the developing sympathetic 
neurons of the mouse superior cervical sympathetic 
ganglion (SCG) in vivo and in vitro. At El3, the SCG 
contains proliferating cells that express many features 
of differentiated neurons. These immature neurons sur- 
vived in culture without NGF, and NGF did not induce 
c-fos expression. Low levels of p75 and trkA mRNAs 
were expressed at this stage in vivo. There was no sig- 
nificant increase in the level of either trkA mRNA or 
p75 mRNA in El3 control cultures up to 72 h in vitro, 
and neither NGF nor depolarizing levels of K + ions (40 
mM KCI) affected the expression of trkA mRNA. In 
El4 cultures, NGF induced c-fos expression in 10-15% 
of the neurons and enhanced the survival of a similar 
percentage of neurons. The proportion of neurons re- 
sponding to NGF increased with age, reaching 90% in 
E18 cultures. The in vivo level of trkA mRNA in- 
creased markedly from E14 onward, but in contrast to 
sensory neurons (in which p75 and trkA mRNA levels 
increase in parallel), the level of trkA mRNA initially 
increased far more rapidly than that of p75 mRNA. Af- 
ter El7, the level of p75 mRNA increased rapidly and 
approached that of trkA mRNA postnatally, but at no 
stage did this exceed the level of trkA mRNA. In El4 
cultures, the level of trkA mRNA increased in the ab- 
sence of neurotrophins or 40 mM KC1. The level of p75 
mRNA in El4 cultures was enhanced by NGF but was 
unaffected by 40 mM KC1. Our findings show that NGF 
receptor expression during the earliest stages of sympa- 
thetic neuron development is not affected by depolar- 
ization but indicate that by an early developmental 
stage (between E13 and El4 in vivo), sympathetic neu- 
rons become specified to upregulate trkA mRNA in 
culture independently of added factors. In addition, our 
findings reveal several distinctive features of p75 
mRNA and trkA mRNA expression in sympathetic 
neurons compared with sensory neurons and provide a 
plausible explanation for previously observed differ- 
ences in the effects of a p75 null mutation on the re- 
sponse of sensory and sympathetic neurons during em- 
bryonic and postnatal development. 
N 
'GF  is  the  founder  member  of  a  family  of ho- 
modimeric  proteins  termed  neurotrophins  that 
promote and regulate the survival of many kinds 
of neurons in the  developing vertebrate nervous system 
(Davies, 1994). Experimental manipulation of NGF levels 
during development (Levi-Montalcini, 1987)  and studies 
of mice with null mutations in the NGF gene (Crowley et 
al., 1994) and NGF receptor tyrosine kinase gene (Smeyne 
et al., 1994) have clearly shown that NGF is required for 
the survival of developing sympathetic neurons and a sub- 
set of sensory neurons that includes nociceptive and ther- 
moceptive neurons. 
NGF exerts its effects on responsive neurons by binding 
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to  two  transmembrane  glycoproteins:  TrkA  and  p75. 
TrkA has a cytoplasmic tyrosine kinase domain that un- 
dergoes  rapid  transphosphorylation  after  NGF  binding 
(Kaplan et al., 1991; Klein et al., 1991). Expression studies 
in  cell  lines  (Cordon-Cardo  et  al.,  1991)  and  neurons 
(Allsopp et al.,  1993) indicate that TrkA is essential for 
NGF responsiveness. Although p75 is probably not a func- 
tional NGF receptor alone  (Hempstead et al.,  1989), in 
vitro studies of the  action of NGF on neurons obtained 
from p75-/- mice indicate that p75 modulates the response 
of neurons to NGF. Compared with wild-type embryonic 
sensory neurons, p75-deficient embryonic sensory neurons 
are fourfold less sensitive to NGF in the mid-concentra- 
tion range (Davies et al.,  1993b; Lee et al., 1994).  Intrigu- 
ingly, the NGF dose response of embryonic p75-deficient 
sympathetic neurons is normal (Davies et al., 1993b) and 
only becomes shifted to higher NGF concentrations post- 
natally (Lee et al., 1994). How p75 enhances the response 
of embryonic sensory and postnatal sympathetic neurons 
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fects of the p75 mutation on the response of sympathetic 
neurons to NGF is not understood. 
Detailed  quantitative  information  on  the  timing  and 
regulation of NGF receptor genes during development is 
currently available for the sensory neurons of the embry- 
onic mouse  trigeminal  ganglion.  These neurons  initially 
survive independently of neurotrophins when their axons 
are growing to their peripheral targets and are briefly sup- 
ported by brain-derived neurotrophic factor (BDNF), neu- 
rotrophin-3 (NT3), or NT4/5 when their axons reach these 
targets. Shortly afterward, the neurons become dependent 
on NGF and lose dependence on BDNF, NT3, or NT4/5 
(Davies and Lumsden, 1984; Buchman and Davies, 1993; 
Davies et al., 1993).  Although trigeminal neurons express 
low levels of p75 and trkA mRNAs from the earliest stages 
of their development, the acquisition of NGF dependence 
is correlated with marked increases in the levels of both 
p75 mRNA (Wyatt et al., 1990) and trkA mRNA (Wyatt 
and Davies, 1993) and the ability of the neurons to bind 
NGF (Davies et al.,  1987).  Although NGF maintains  or 
upregulates the level of p75 mRNA in short-term cultures 
of El2 trigeminal neurons (the stage when many neurons 
acquire NGF dependence), the level of trkA mRNA  in- 
creases in these cultures, irrespective of the presence of 
NGF (Wyatt and Davies, 1993), suggesting that the devel- 
opmental increase in trkA mRNA is not induced by NGF. 
The age-related effects of the p75 null mutation on the 
response of developing sympathetic neurons to NGF (Da- 
vies et al., 1993b; Lee et al., 1994) have raised the intrigu- 
ing possibility that the levels of p75 and TrkA in sympa- 
thetic neurons may have different developmental patterns 
of expression from those in sensory neurons. Moreover, 
studies of the regulation of p75 and trkA mRNA expres- 
sion in cell lines of the sympathoadrenal lineage raise the 
possibility that the expression of NGF receptor genes may 
be regulated differently in sympathetic and sensory neu- 
rons. In PC12 cells,  a pheochromocytoma-derived cell line 
that stops dividing and differentiates into sympathetic-like 
neurons after NGF exposure, NGF increases the expres- 
sion of both p75 mRNA (Doherty et al.,  1988) and trkA 
mRNA (Hottzman et al.,  1992).  In MAH cells, a retrovi- 
rally immortalized  sympathoadrenal progenitor cell line 
(Birren and Anderson, 1990), trkA mRNA is induced by 
depolarizing levels of KC1 but not by NGF (Birren et al., 
1992), whereas  depolarizing levels of KC1  do not  affect 
trkA  mRNA  expression  in  developing sensory neurons 
(Wyatt and Davies, 1993).  These observations prompted 
us to determine the normal developmental time-course of 
p75  and  trkA  mRNA  expression in normal sympathetic 
neurons and to investigate the role of NGF and depolar- 
ization on p75  and  trkA  mRNA  expression at  different 
stages of development. 
We chose to investigate p75 mRNA  and trkA mRNA 
expression in the developing mouse superior cervical sym- 
pathetic ganglion (SCG). 1 This large collection of sympa- 
thetic neurons can be dissected from the embryo as early 
as El3, before the immature neurons acquire survival de- 
pendence on NGF (Coughlin and Collins,  1985).  At this 
1. Abbreviations used in this paper: RT, reverse transcription; SCG, mouse 
superior cervical sympathetic ganglion. 
early  stage,  mammalian  and  avian  sympathetic  ganglia 
contain many dividing cells that possess a variety of neu- 
ronal  characteristics,  including  catecholamines  (Cohen, 
1974), dense-core vesicles, high-affinity noradrenaline up- 
take (Rothman et al.,  1978), tyrosine hydroxylase (Roth- 
man  et  al.,  1980),  tetanus  toxin  receptor  (Rohrer  and 
Thoenen, 1987), neuron-specific antigens SCG10, B2 (An- 
derson and Axel, 1986) and Q211  (Rohrer and Thoenen, 
1987), neurofilament protein (DiCicco-Bloom and Black, 
1988), and neuritic processes (DiCicco-Bloom et al., 1990). 
These  proliferating,  neuronlike  cells  have  been  termed 
precursor  cells  (Anderson  and  Axel,  1986),  neuroblasts 
(DiCicco-Bloom and Black, 1988), and immature neurons 
(Ernsburger et al.,  1989a). Because these cells express so 
many of the properties that are used as markers for differ- 
entiated sympathetic neurons, we prefer to refer to these 
cells as immature sympathetic neurons (Rohrer, 1990). 
Like early trigeminal  neurons  (Buchman  and  Davies, 
1993; Davies et al., 1993a), immature sympathetic neurons 
appear to undergo a switch in neurotrophin dependence, 
in this case from NT3 to NGF. Although many immature 
sympathetic neurons  survive for several  days  in  culture 
(Ernsberger et al.,  1989a), NT3 enhances the survival of 
these cells before they become dependent on NGF for sur- 
vival (Birren et al.,  1993; Dechant et al.,  1993;  DiCicco- 
Bloom et al.,  1993).  In  situ  hybridization and  Northern 
blotting have shown that trkC mRNA expression precedes 
trkA  mRNA  expression in  developing sympathetic gan- 
glia, suggesting that the switch in neurotrophin responsive- 
ness is  a  result of the sequential expression of NT3 and 
NGF receptor tyrosine kinases (Birren et al., 1993; DiCicco- 
Bloom et al., 1993). 
In the study reported here, we show that expression of 
trkA and p75 mRNAs in immature sympathetic neurons is 
unaffected by depolarization or retinoic acid and that, by 
an early stage in their development, sympathetic neurons 
acquire the capacity to upregulate trkA mRNA expression 
in vitro independently of added factors. Major differences 
in the developmental profile of p75 and trkA mRNA ex- 
pression  in  sympathetic and  sensory neurons  provide a 
plausible explanation for the age-related difference in the 
effects of the p75 null mutation on NGF responsiveness in 
developing sympathetic and sensory neurons. 
Materials and Methods 
Neuron Cultures 
Mouse embryos were  obtained  from overnight matings of CD1  mice. 
Pregnant females were killed by cervical dislocation, and the precise stage 
of development of the embryos was determined by the criteria of Theiler 
(1972).  Electrolytically sharpened tungsten needles were used to dissect 
SCGs from embryonic day 13 (El3) embryos to postnatal day 1 (PND1) 
neonates. Ganglia were incubated from 5 to 15 rain (depending on age) at 
37°C with 0.05% trypsin (Worthington Biochemical Corp., Freehold, N J) 
in calcium- and magnesium-free HBSS. After removal of the trypsin solu- 
tion, the ganglia were washed twice with 10 ml of Ham's F12 medium con- 
taining 10% heat-inactivated horse serum and were gently triturated with 
a fire-polished, siliconized Pasteur pipette to give a single cell suspension. 
The cells were plated in 35-ram plastic tissue culture dishes (1,200-2,000 
neurons per dish; Nunc, Roskilde, Denmark) that had been precoated 
with polyornithine (0.5 mg/ml, over night) and laminin (20 I~g/ml for 4 h). 
The cultures were incubated at 37°C in a humidified 4% CO2 incubator. 
For studying the effects of NGF on neuronal survival and c-los induction, 
Ham's F14 medium supplemented with 10% heat-inactivated horse serum 
(Gibco Laboratories, Grand Island, NY), 60 mg/ml penicillin, and 100 mg/ 
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expression of p75 mRNA and trkA mRNA expression, a defined medium 
consisting of Ham's F14 supplemented with 2 mM glutamine, 0.35% BSA 
(Pathocyte-4, ICN Biomedicals, Irvine, CA), 60 ng/ml progesterone, 16 
~g/ml putrescine, 400 ng/ml L-thyroxin, 38 ng/ml sodium selenite, 340 ng/ 
ml tri-iodothyronine, 60 mg/ml penicillin, and 100 mg/ml streptomycin was 
used. A limited number of experiments showed that the NGF survival re- 
sponse of developing SCG neurons was very similar to that for neurons 
grown in serum-supplemented  medium and in defined medium. 
Neuronal survival was  estimated in control  and NGF-supplemented 
cultures by counting the number of neurons in a 12-×-12-mm grid in the 
center of each 35-mm culture dish after 48 h of incubation. The difference 
in neuronal survival between control and NGF-supplemented cultures at 
different ages is expressed as the difference in the number of neurons in 
control and NGF-supplemented cultures (i.e., a percentage of the number 
of neurons in NGF-supplemented cultures). For studies of the regulation 
of p75 mRNA and trkA mRNA expression, the total number of neurons 
in each dish was estimated immediately before RNA was extracted by 
counting the number of neurons in the 12-×-12-mm grid and multiplying 
this number by the quotient of the total growth area of the dish and the 
grid area. 
Immunocytochemical Detection of c-fos Protein 
To provide an additional measure of the proportion of SCG neurons that 
respond to NGF at each age, immunocytochemistry  was used to estimate 
the proportion of neurons that express the nuclear proto-oncogene c-los 
in response to NGF. For these studies, the neurons were plated in Petri 
dishes containing 4-×-11-mm diameter wells  (Greiner,  Frickenhausen, 
Germany) at a density of 500 cells per well in a final volume of 120 i~1 of 
F14 medium supplemented with 10% heat-inactivated horse serum. After 
NGF exposure, the cultures were rinsed twice with PBS and were fixed in 
fresh 4% paraformaldehyde in PBS for 17 rain at room temperature. Af- 
ter two additional rinses with PBS, the cultures were permeabilized with 
0.3% Triton X-100 in PBS for 30 rain and were incubated overnight at 4°C 
with rabbit polyclonal c-los antiserum diluted in PBS containing 0.3 % Tri- 
ton. Two c-fos antisera were used in separate experiments: an antibody 
raised against a synthetic peptide corresponding to the NH2-terminal se- 
quence of c-fos (Hunt et al., 1987)  was obtained from G. Evan (ICRF, 
London) and was used at a dilution of 1:4,000; and another antibody also 
directed against the NH2-terminal domain of c-fos was obtained from On- 
cogene Science (c-fos/Ab-2; Manhasset, N¥) and was used at a dilution 1: 
100.  After incubation with primary antiserum, the cultures were rinsed 
with PBS and were incubated with biotinylated goat anti-rabbit antiserum 
diluted 1:500 in PBS for 3 h at room temperature followed by additional 
rinses with PBS and incubation for 30 rain at room temperature with an 
avidin/biotinylated HRP macromolecular complex (Vector Laboratories, 
Burlingame, CA). After the cultures were rinsed with PBS, peroxidase ac- 
tivity was localized by incubation with a 0.5 mg/ml DAB solution in PBS 
containing 0.01%  hydrogen peroxide, 0.01%  nickel chloride, and 0.01% 
cobalt chloride. The reaction was stopped after 45-60 s by flooding the 
cultures with PBS. The cultures were then mounted in Aquamount (BDH 
Chemicals, Poole, England) beneath 10-mm diameter coverslips (Chance 
Propper,  London, UK) and were viewed with a  Zeiss Axioskop micro- 
scope after the walls of the Petri dishes were removed. 
c-los expression was recognized by intense nuclear staining. The pro- 
portion of neurons that expressed c-los immunoreactivity was determined 
by examining several microscope fields selected at random. Each field was 
examined with phase contrast optics to count the total number of neurons 
and with bright-field optics to count the number of neurons with darkly 
stained nuclei. At least 100  neurons in each well were  assessed in this 
manner to determine the proportion of c-los positive neurons. 
Measurement of trkA mRNA and p75 mRNA Levels by 
Quantitative RTIPCR 
A quantitative RT/PCR technique (Wyatt and Davies, 1993)  was used to 
measure the very low levels of trkA mRNA and p75 mRNA in SCG neu- 
ron cultures and dissected whole ganglia. The RT reaction and PCR were 
calibrated by the inclusion of control RNA templates in the RT reaction. 
The control RNA templates were transcribed in vitro from trkA and p75 
cDNA clones that had been modified by the insertion between the PCR 
primer sites of 3 bp in the case of trkA cDNA and 4 bp in the case of p75 
cDNA.  Because the  target  mRNA and its control  RNA template  are 
present in the same RT reaction and PCR and use the same primers, the 
variables that affect amplification efficiency are nullified. To generate the 
p75 cDNA control template from which the control RNA template was 
transcribed, a 597-bp fragment of the mouse p75 cDNA corresponding to 
nucleotides 426 to 1023  of the rat p75 cDNA was isolated from mouse 
brain total RNA using RT/PCR and was cloned into pGEM 3Z (Promega 
Biotec, Madison, WI). The 601-bp p75 cDNA control template was con- 
structed by cleaving the cloned p75 cDNA at a single AvaI site to generate 
DNA with 4 bp of 5' overhang at each end. These overhangs were filled in 
with the Klenow fragment of DNA polymerase I in the presence of 5 mM 
dNTPs and ligating the resulting blunt ends. The control p75 cRNA tem- 
plate was synthesized by in vitro transcription of the control p75 cDNA 
from the Sp6 RNA polymerase of the pGEM vector. To generate the trkA 
cDNA control template, a 452-bp fragment of the mouse trkA cDNA cor- 
responding to nucleotides 838 to 1290 was cloned into pGEM 3Z and was 
cleaved at a single internal PpUMI site to generate DNA with 3 bp of 5' 
overhang at each end that were filled in and ligated as before. The result- 
ing 455-bp cDNA was transcribed from the Sp6 RNA polymerase of the 
pGEM vector to produce the trkA RNA control template. 
Total  RNA  (Chomczynski  and  Sacchi,  1987),  spiked  with  known 
amounts of the appropriate control RNA, was reverse transcribed for 45 
rain at 37°C with GIBCO BRL Superscript enzyme (Gaithersburg, MD) 
in a  10 Ixl reaction containing the manufacturer's buffer supplemented 
with 0.5 mM dNTPs and 10 ~M random hexanucleotides. Each RT reac- 
tion was then gently mixed with a  40-1xl PCR solution comprising 1  × 
NBL Taq DNA polymerase buffer (with an additional 0.4 mM MgCI2 in 
the case of p75),  1 U  of NBL Taq DNA polymerase, 40 ng of 5'  end- 
labeled  primers,  and  0.1  mM dNTPs.  The  primers  for  p75  were  (5') 
5'-CCGATACAGTGACCACTGTGATG-3'  and  (3')  5'-AGCAGC- 
CAAGATGGAGCAATAGAC-3'. These hybridize 97 bp apart in the 
sequence of mouse p75 cDNA and 101 bp apart in the p75 control cDNA. 
The primers for trkA  were  (5')  5'-CGTCATGGCTGCqTITATGG-3' 
and (3') 5'-ACTGGCGAGAAGGAGACAG-3'. These hybridize 75 bp 
apart in the sequence of mouse trkA cDNA and 78 bp apart in trkA con- 
trol cDNA. 
p75 cDNA was amplified by eight cycles of 94°C for 60 s, 58°C for 60 s, 
and 72°C for 60 s, followed by 15 cycles of 91°C for 60 s, 56°C for 45 s, and 
72°C for 60 s. trkA cDNA was amplified by eight cycles of 94°C for 60 s, 
56°C for 45 s, and 72°C for 45 s, followed by 12 cycles of 90°C for 60 s, 55°C 
for 60 s, and 72°C for 60 s. These conditions were optimal for RT and am- 
plification of 1 fg of trkA and p75 control transcripts, respectively, such 
that the rate of reaction did not plateau. If reactions were allowed to reach 
the plateau phase, the formation of heteroduplex DNA products during 
this phase altered the ratio between homoduplex products, leading to in- 
accuracies. 
The PCR products of the control and native cDNA templates were re- 
solved on 7% nondenaturing polyacrylamide gels that were dried and au- 
toradiographed. Reactions were set up such that the autoradiographic sig- 
nals from the PCR products of the native and control cDNA templates 
were approximately equal. The autoradiographs were scanned with a den- 
sitometer (Personal Laser, Molecular Dynamics, Inc., Sunnyvale, CA), 
and  the  intensity of  the  respective  signals was  ascertained  using Im- 
ageQuant software (Molecular Dynamics). These values enabled the lev- 
els of p75 mRNA or trkA mRNA in the initial total RNA sample to be 
calculated. 
To compare the relative levels of p75 and trkA mRNAs in different 
preparations of purified neurons, the level of the mRNA encoding the 
ubiquitous, constitutively expressed L27 ribosomal protein was also mea- 
sured in RNA samples from these neurons by quantitative RT/PCR. To 
determine the level of L27 mRNA, 10-1xl aliquots of reverse transcribed 
neuronal total  RNA  were  added  to  50-1xl PCRs  containing NBL Taq 
DNA polymerase in the supplied buffer plus 5  ~1 of the following la- 
beled  primers:  (5')5'-GAAGAACATCGATGATGGCAC-3'  and  (3') 
5'-TAGCGGTCGATI'CCAGCCACC-3'. These hybridize 75 bp apart in 
the L27 sequence and were labeled as described for the trkA  and p75 
primers. L27 cDNA was amplified by 25 cycles of 92°C for 60 s, 55°C for 
60 s, and 72°C for 60 s. There was a final 72°C incubation for 10 rain. These 
conditions are optimal for RT and amplification of 500 fg of L27 gene run- 
off transcripts such that the rate of reaction does not plateau. The level of 
L27 mRNA in the extracted RNA was quantified by coamplifying with 
standard run-off transcripts from the L27 cDNA, which have an addi- 
tional 4-bp insert between the primer annealing sites. 
Purification of SCG Neurons 
For measurement of p75 mRNA and trkA mRNA levels in purified SCG 
neurons, these neurons were  separated from satellite  cells in E16  and 
older  SCGs  by  low-temperature,  differential  sedimentation  (Davies, 
Wyatt and Davies Regulation of  p75 and trkA Expression  1437 Results 
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To  determine  when  SCG  neurons  start  responding  to 
NGF during development, two variables of NGF respon- 
siveness were studied--neuronal survival and c-los induc- 
tion. 
Developmental Changes in the Survival Response of 
SCG Neurons to NGF 
Dissociated, low-density cultures of E13 to El8 SCG neu- 
rons were grown in control cultures and cultures contain- 
ing 10 ng/ml NGF. In El3 cultures, the majority of the im- 
mature neurons survived for 48 h  of incubation in control 
cultures, there was no difference in the number of neurons 
in  control  and  NGF-supplemented cultures.  In  El4  cul- 
tures, 15-20%  more neurons were surviving in NGF-sup- 
plemented cultures after 48 h of incubation compared with 
control cultures (Fig. 1 A). The magnitude of the NGF sur- 
vival response increased with age, and  by E18  the great 
majority of neurons were surviving with NGF (Fig. 1 A). 
Thus, the first SCG neurons become dependent on NGF 
for survival at or shortly after El4, and the majority of the 
remaining neurons become NGF dependent over the next 
5 days of development. 
The  dose  response  of  El8  SCG  neurons  to  NGF  is 
shown  in Fig.  1  B.  Interpolation  of the  data  revealed  a 
half-maximally effective NGF concentration of 134 pg/ml. 
Because  saturation was reached  at a  concentration of 10 
ng/ml, this level of NGF was  used in subsequent  experi- 
ments. 
Developmental Changes in c-fos Induction by NGF 
Initial experiments showed that 2  h  of NGF exposure in- 
duced c-los expression in about 80% of El8 SCG neurons, 
whereas <1%  of the neurons were labeled in control cul- 
tures (no NGF). The same results were obtained with both 
c-los antisera,  but  because  the c-los antiserum  obtained 
from G. Evan gave the most intense nuclear staining, this 
was used in subsequent  experiments. No nuclear staining 
was observed when the c-los antiserum was omitted. 
To determine the time-course of c-los induction, NGF 
was added to E18 SCG neurons 2 h after plating. After in- 
cubation periods with NGF ranging from 15 min to 6 h, the 
cultures  were  processed for c-los immunoreactivity.  Ex- 
pression of c-los was first discernible in a small number of 
neurons after 30 min of NGF exposure, increased to maxi- 
mum  after 3  h  of NGF exposure and declined thereafter 
(Fig. 2 A). The intensity of nuclear staining was also maxi- 
mal after 3 h. For these reasons, neurons were exposed to 
NGF for 3 h in subsequent studies of c-los expression. The 




1986).  Briefly,  SCGs were  dissected in  ice-cold HBSS,  incubated with 
0.05%  trypsin (Worthington Biochemical Corp.)  in phosphate-buffered 
saline for 10 min at 37°C, washed in HBSS containing 10%  heat-inacti- 
vated horse serum (HIHS), and dissociated in serum-free HBSS by gentle 
trituration with a fire-polished Pasteur pipette. The resulting cell suspen- 
sion was layered on a precooled column of HBSS containing 10% HIHS 
in a dropping funnel at 2°C. After 60 rain, aliquots were removed and the 
fractions containing neurons were  identified  by phase-contrast micros- 
copy. The neurons were pelleted in siliconized Eppendorf tubes, frozen, 
and stored at -80°C until required. 
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Figure 1.  Survival response of developing SCG neurons to NGF. 
(A) Cultures of El3 to El8 SCG neurons were grown under con- 
trol conditions (no NGF) and with NGF (10 ng/ml) for 48 h of in- 
cubation, when the number of surviving neurons were counted. 
The difference between survival in NGF-supplemented cultures 
and control cultures is expressed as a percentage of the survival 
in NGF-supplemented cultures. The means and the standard er- 
rors of three separate experiments are plotted. (B) El8 SCG neu- 
rons were grown with different concentrations of NGF, and the 
percentage of survival was estimated after 48 h of incubation. The 
means and the standard errors of three separate experiments are 
plotted. 
NGF is shown  in Fig. 2  B.  Interpolation of the  data re- 
vealed  a  half-maximally effective NGF  concentration  of 
118 pg/ml, which is very similar to the half-maximally ef- 
fective  NGF  concentration  for  promoting  neuronal  sur- 
vival. 
To ascertain the developmental changes in c-fos induc- 
tion by NGF, cultures of SCG neurons were set up at daily 
intervals from El3 to El8. The neurons were grown either 
in the absence of NGF (control cultures) or with 10 ng/ml 
NGF. After 3 h  of incubation, the cultures were fixed and 
processed  for  c-fos  immunoreactivity.  In  El3  cultures, 
NGF did not induce c-fos expression in any neurons.  In 
El4 cultures, NGF induced c-los expression in ~10%  of 
the neurons. The percentage of c-fos induction by NGF in- 
creased with age to reach >80%  in El7 and E18 cultures 
(Fig. 3). Thus, both the survival response of SCG neurons 
to NGF and the induction of c-fos by NGF follow the same 
developmental  time  course,  indicating  that  the  earliest 
neurons respond to NGF at or shortly after El4. 
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Figure 2.  Induction of c-los in cultured SCG neurons by NGF. 
(A) Time-course of c-fos induction by NGF in El8 SCG neurons. 
The percentage of c-fos-positive neurons is plotted against time 
of NGF exposure. The means and the SEMs of three separate es- 
timates of c-fos induction are plotted. (B) c-los induction dose- 
response of El8 SCG neurons to NGF. El8 SCG neurons were 
exposed to different concentrations of NGF for 3 h  before fixa- 
tion and estimation of the percentage of c-los-positive neurons. 
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Figure 3.  Age-related  changes in c-los induction in developing 
SCG neurons  by NGF.  Cultures  of El3  to El8 SCG neurons 
were exposed to NGF for 3 h. The percentage of c-fos-positive 
neurons is plotted at each age. The means and the standard errors 
of three separate estimates of c-fos induction are plotted. 
mRNA level by birth (Fig. 4). A limited number of assays 
at later ages indicated that the relative level of p75 mRNA 
reached 60%  of that of trkA mRNA by PND3 (data not 
shown). 
Although the majority of ceils in the early sympathetic 
chain  are  proliferating  immature  sympathetic  neurons 
(Rohrer  and  Thoenen,  1987;  Ernsberger  et  al.,  1989a, 
1989b;  Rohrer, 1990),  at later ages an increasing propor- 
tion of satellite cells is present in the ganglion. To deter- 
mine if p75 mRNA and trkA mRNA are expressed pre- 
dominantly  in  neurons,  differential  sedimentation  was 
used to prepare purified neurons (greater than 95% neu- 
rons) from El7 and newborn SCGs. RT/PCR assays using 
RNA extracted from these neurons and from whole gan- 
glia at the same age showed that the relative levels of trkA 
mRNA to p75 mRNA were very similar in purified neu- 
rons  and whole  ganglia (Fig.  5).  These  findings indicate 
that the relative levels of trkA mRNA to p75 mRNA ob- 
served in whole ganglia during development (Fig. 4) accu- 
Developmental Time Course of  p75 mRNA and trkA 
mRNA Expression in SCGs 
Quantitative RT/PCR was carried out to determine levels 
of p75 mRNA and trkA mRNA in SCGs at daily intervals 
from E13 to PND1. The sensitivity, specificity, and accu- 
racy of the competitive RT/PCR technique used for quan- 
tifying the absolute levels of these mRNAs have been doc- 
umented previously (Wyatt and Davies, 1993). Low levels 
of p75 mRNA and trkA mRNA were present in the SCGs 
at E13 and El4 (Fig. 4). Although the levels of p75 mRNA 
and trkA mRNA were similar  at E14, between E14 and 
E15, the level of trkA mRNA increased more than sixfold. 
In contrast, the level of p75 mRNA showed only a small 
increase over the same period (Fig.  4). The level of trkA 
mRNA continued to increase  with  age, reaching almost 
100 pg per ganglion just before birth. In contrast with trkA 
mRNA, the level of p75 mRNA increased only very grad- 
ually until E17, when its level was only 15%  of the trkA 
mRNA level. After E17, the level of p75 mRNA increased 
more rapidly in the  ganglion, reaching 38%  of the trkA 
Receptor mRNA expression in SCG 
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Figure 4.  Graph of the levels of p75 mRNA and trkA mRNA per 
SCG from El3 to PND1. The inset shows in detail the changes 
occurring in p75 mRNA and trkA mRNA expression occurring 
between El3 and El5. The means +- SEM of at least four sepa- 
rate measurements at each age are shown. 
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Figure 5.  Bar chart of the relative levels of p75 mRNA and trkA 
mRNA in whole SCG and purified SCG neurons from E17 em- 
bryos and postnatal day 1 neonates.  In each of three separate 
preparations of neurons, there was <5 % contamination by satel- 
lite cells. The relative levels of p75 and trkA mRNAs in different 
neuronal preparations were determined by standardizing the lev- 
els of p75 and trkA mRNAs to the level of L27 mRNA in these 
preparations. To compare the relative levels of mean levels of 
p75 mRNA and trkA mRNA in whole ganglia and purified neu- 
rons, the mean levels of trkA mRNA were normalized to 100%. 
The means -  SEM for three separate estimations of p75 mRNA 
and trkA mRNA in ganglia and purified neurons are plol~ted. 
per neuron  under different experimental conditions. The 
levels of p75 mRNA  and trkA mRNA  were measured in 
all dishes. 
trkA mRNA 
The low mean neuronal level of trkA mRNA expression in 
E13  control  cultures  (no  added  factors)  was  unchanged 
between 24 and 72 h  in vitro (Fig. 6 A). In these control 
cultures  <1%  of the  neurons  died between  24  and  48  h 
and 40.3  __+ 3.2%  (mean  _+ SEM) of the neurons were lost 
between 48 and 72 h.  In contrast, in El4 control cultures 
the mean neuronal level of trkA mRNA  increased about 
threefold between 24 and 48 h  in vitro (Fig. 7 A). In these 
experimental cultures, 27  -+ 6.7%  of the neurons died be- 
tween 24 and 48 h. 
Because  neurons  increase  in  size  with  time  in  culture 
and the total amount  of RNA  per neuron increases con- 
comitantly, it is possible that the increase in trkA mRNA 
levels that we observed between 24  and 48 h  in E14 cul- 
rately reflect relative levels of these mRNAs in the sympa- 
thetic neurons. 
Regulation of  p75 mRNA and trkA mRNA Expression 
To investigate the extent to which the developmental in- 
creases in trkA mRNA  and p75 mRNA  expression are in- 
fluenced by NGF or depolarization, low density cultures of 
the immature neurons in E13 and E14 SCG were studied 
at intervals in culture. An advantage of studying neurotro- 
phin receptor expression in these early neuronal cultures 
is that  the majority of the immature  neurons  survive for 
several days in the absence of NGF (more than 3 d in El3 
cultures and more than 2 d in El4 cultures). Also, because 
at this stage the SCGs consist predominantly of immature 
neurons, there is negligible contamination by nonneuronal 
cells in these cultures. Positive identification of immature 
neurons  by  neurofilament  immunocytochemistry  (Buch- 
man and Davies, 1993)  showed that the great majority of 
cells in early SCG cultures were neurons. In E14 cultures, 
nonneuronal  cells constituted only 2.8  -  0.4%  (mean  _-+ 
SEM) of the cells after 24 h  in defined medium and 3.0 
0.6% of the cells after 48 h. 
In each experiment, approximately the same number of 
cells were plated in 35-mm culture dishes (<5%  variation 
between  dishes in each experiment). Typically, the num- 
ber of cells plated ranged  between  1,200  and  2,000  cells 
per dish in different experiments. There was no significant 
difference (P >  0.05, Student's t test) in the number of im- 
mature neurons grown under different experimental con- 
ditions in E13  cultures, and in E14 cultures ~20%  more 
neurons died in control cultures between 24 and 48 h com- 
pared with cultures supplemented with NGF at concentra- 
tions >0.4 ng/ml. Because the number of neurons in each 
dish was  counted  before  RNA  extraction,  differences in 
neuron number between dishes were taken into account in 
calculating the mean level of p75 mRNA and trkA mRNA 
Figure 6.  Bar charts of the levels of (A) trkA mRNA and (B) p75 
mRNA per neuron in cultures of El3 SCG neurons grown for 24, 
48, and 72 h in unsupplemented culture medium (Cont), with 10 
ng/ml NGF, 40 mM KC1, or NGF plus KC1. The bar charts show 
the mean and standard error of results from three separate exper- 
iments (each with triplicate culture dishes for each condition at 
each time point). 
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mRNA per neuron in cultures of El4 SCG neurons grown for 24 
and 48 h in unsupplemented  culture medium (Cont), with 10 ng/ 
ml NGF, 40 mM KC1, or NGF plus KC1. The bar charts show the 
mean and standard  error of results from three  separate  experi- 
ments (each with triplicate culture dishes for each condition at 
each time point). 
tures  was  nonspeciflc and  reflected  a  growth-related in- 
crease in total mRNA content per neuron. To address this 
issue,  we  used  RT/PCR  to  measure  the  levels  of  L27 
mRNA (which codes for a  ubiquitous, constitutively ex- 
pressed ribosomal protein) in El4 cultures after 24 and 48 h 
of incubation.  In contrast with the  threefold increase  in 
trkA mRNA levels observed between 24 and 48 h, there 
was only a 32% increase in the level of L27 mRNA (from 
112.4  2  12.4 fg to 148.3  ±  24.4 fg per neuron). Thus, the 
increase in trkA mRNA observed in El4 cultures is not a 
consequence of a  nonspecific growth-related increase  in 
total mRNA content. 
The presence of NGF did not affect the expression of 
trkA mRNA in either 1213 or El4 cultures. There was no 
significant difference between the mean neuronal level of 
trkA mRNA in  control cultures  and  cultures  containing 
NGF  at  matching  time  points  in  E13  cultures  and  at 
matching time points in 1214 cultures (P >  0.05, t test). The 
increase  in  trkA  mRNA expression  that  occurs  in  E14 
neurons between 24 and 48 h was of the same magnitude 
in the presence and absence of NGF. Thus, the develop- 
mental increase in trkA mRNA expression is independent 
of NGF.  NGF was used  at  concentrations ranging from 
0.016  ng/ml to 250 ng/ml (0.016,  0.08, 0.4,  10, 50, and 250 
ng/ml). Because there was no significant difference in the 
levels of trkA mRNA in different concentrations of NGF 
used (data not shown), only results with 10 ng/ml NGF are 
shown (Figs. 6 A and 7 A). At later ages, when the neurons 
become increasingly dependent on NGF for survival, ex- 
posing neurons  to  a  wide  range  of NGF concentrations 
above the  minimum required  for the  maximal  neuronal 
survival did not significantly affect the expression of trkA 
mRNA (Fig. 9). 
Depolarizing levels  of KCI  (40  mM)  did  not  increase 
trkA mRNA expression in either El3 or E14 cultures (Fig. 
6 A and 7 A). There was no significant difference between 
the  mean neuronal level  of trkA mRNA in control cul- 
tures and cultures containing 40 mM KCI at the same time 
points in E13 cultures (P >  0.05, t test). The level of trkA 
mRNA was slightly lower in El4 cultures  containing 40 
mM KC1 compared with control cultures at this age. Fur- 
thermore, exposure of E13 or El4 cultures to 40 mM KC1 
plus NGF did not significantly increase the expression of 
trkA  mRNA  compared  with  cultures  containing  NGF 
alone (P >  0.05,  t test).  In E18 cultures, when the  great 
majority  of  neurons  depend  on  NGF  for  survival,  the 
mean neuronal level of trkA mRNA was not significantly 
different between cultures containing NGF alone and cul- 
tures containing NGF plus 40 mM KC1 (P >  0.05, t test) af- 
ter both 24 and 48 h of incubation (Fig. 8 A). 
Because retinoic acid has  been shown to induce NGF 
survival  dependence  and  high-affinity NGF receptors in 
immature  sympathetic  neurons  from  chicken  embryos 
(Rodriguez-Tebar  and  Rohrer,  1991),  we  investigated 
whether retinoic acid induces trkA mRNA expression in 
immature sympathetic neurons from mouse embryos. El3 
SCG cultures  were  grown with  a  range  of retinoic  acid 
concentrations with and without NGF in the culture me- 
dium.  For all  experiments,  a  fresh batch of retinoic acid 
was dissolved in the dark in a small volume of ethanol im- 
mediately before being diluted in culture medium (control 
cultures received the same volume of ethanol). Because of 
the light sensitivity of retinoic acid, the cultures were kept 
in the dark until RNA extraction. After 48 h of incubation, 
the level of trkA mRNA in control cultures (0.067 +- 0.010 
fg/neuron) was very similar to that in cultures containing 
retinoic acid alone at concentrations of 10 .9  M,  10 .8  M, 
10 .7 M, and 10 .6 M (0.055  ___ 0.004, 0.052  ±  0.009, 0.053  ± 
0.015,  and 0.037  ±  0.008, respectively; mean ±  SEM) and 
cultures  containing  the  same  concentrations  of retinoic 
acid plus  10  ng/ml NGF  (0.068  ±  0.002,  0.057  ±  0.009, 
0.060  ±  0.004,  and 0.040  ±  0.008,  respectively; n  =  3 per 
experimental condition). Thus, retinoic acid does not in- 
duce  trkA  mRNA  expression  in  immature  sympathetic 
neurons. 
Because NT3 promotes the survival of immature sympa- 
thetic neurons (Birren  et al.,  1993; Dechant et  al.,  1993; 
DiCicco-Bloom et al.,  1993),  we also investigated the ef- 
fect of NT3 on trkA mRNA expression. E13 SCG cultures 
were grown without added neurotrophins and with 2 ng/ml 
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Figure 8.  Bar charts of the levels of (A) trkA mRNA and (B) p75 
mRNA per neuron in cultures of El8 SCG neurons grown for 24 
and 48 h with 10 ng/ml NGF or NGF plus 40 mM KC1. The bar 
charts show the mean and standard  error of results from three 
separate experiments (each with triplicate culture dishes for each 
condition at each time point). 
NT3.  In these  experiments,  the  level  of trkA mRNA in 
control cultures  after 48 h  was 0.032  -+  0.013  fg/neuron 
compared with 0.035  _+  0.017  fg/neuron in cultures  con- 
taining  NT3,  indicating  that  NT3  at  this  concentration 
does not induce trkA mRNA expression. 
p75 mRNA 
In contrast to the lack of effect of NGF on trkA mRNA 
expression in early sympathetic neurons, NGF affected the 
expression of p75 mRNA in E14 cultures. Although there 
was  little  difference  in  the  mean  neuronal  level  of p75 
mRNA in control and NGF-supplemented cultures after 
24 h of incubation in E14 cultures, the mean neuronal level 
of  p75  mRNA  in  NGF-supplemented  cultures  had  in- 
creased  to  almost  sixfold  of its  level  in  control cultures 
(Fig.  7 B). NGF was used at concentrations ranging from 
0.016 ng/ml to 250 ng/ml (0.016,  0.08, 0.4,  10, 50, and 250 
ng/ml). Because the effect of NGF on p75 mRNA induc- 
tion is maximal at concentrations of NGF in excess of 0.4 
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Figure 9.  Graphs of the levels of trkA mRNA and p75 mRNA 
per neuron in cultures of El8 SCG neurons grown for 24 h with 
NGF at concentrations ranging from 0.4 to 250 ng/ml. The means 
and standard errors of three separate experiments are plotted. 
ng/ml (data not shown), only results  with  10 ng/ml NGF 
are  shown  (Fig.  7  B).  The  mean  neuronal  level  of p75 
mRNA in E13 cultures was also higher in the presence of 
NGF compared with control cultures after 48 and 72 h of 
incubation; however, this  difference was not statistically 
significant (P >  0.05, t test). Like trkA mRNA, the level of 
p75 mRNA in El8 cultures was not affected by a range of 
NGF  concentrations  above  those  required  to  promote 
maximal neuronal survival after either 24 h of incubation 
(Fig. 9), or 48 or 72 h of incubation (data not shown). 
At E13  and  E14,  depolarizing levels  of KC1  (40 mM) 
had little effect on p75 mRNA expression. In El3 cultures 
the mean neuronal level of p75 mRNA in control cultures 
was not significantly greater than in cultures containing 40 
mM KC1 after 24 and 48 h (P >  0.05, t test) (Fig.  6 B). Al- 
though the level of p75 mRNA was slightly higher in El4 
cultures  containing 40  mM  KC1  compared  with  control 
cultures, this was negligible compared with the marked ef- 
fect of NGF on the expression of p75 mRNA after 48 h of 
incubation (Fig.  7 B). In El8 cultures, the mean neuronal 
level of p75 mRNA was not significantly different between 
cultures  containing  NGF  alone  and  cultures  containing 
NGF plus 40 mM KC1 (P >  0.05, t test; Fig. 8 B). 
We also investigated whether retinoic acid induces p75 
mRNA expression in immature sympathetic neurons. El3 
SCG cultures  were  grown with  a  range  of retinoic  acid 
concentrations with and without NGF in the culture me- 
dium. After 48 h of incubation, the level of p75 mRNA in 
control  cultures  (0.046  _+  0.017  fg/neuron)  was  greater 
than in cultures containing retinoic acid alone at concen- 
trations of 10 -9 M, 10 -8 M, 10  7 M, and 10 -6 M  (0.038  - 
0.006,  0.027,  0.014  -+  0.0005,  and  0.017  -  0.009,  respec- 
tively; mean _+ SEM). Likewise, the level of p75 mRNA in 
cultures containing 10 ng/ml NGF (0.072  -  0.003  fg/neu- 
ton) was greater than in cultures containing NGF plus the 
same range of retinoic acid concentrations (0.067  --- 0.011, 
0.048  _+  0.014,  0.037  _+  0.007,  and 0.025  _+  0.006,  respec- 
tively; n  =  3 per experimental condition). Thus, retinoic 
acid does not induce the expression of p75 mRNA in im- 
mature sympathetic neurons. 
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expression in immature sympathetic neurons by culturing 
E13 SCG neurons with and without NT3. In these experi- 
ments, the level of p75 mRNA in control cultures after 48 h 
was 0.023  -+ 0.006 fg/neuron compared with 0.029 -  0.011 
fg/neuron in cultures  containing 2  ng/ml NT3, indicating 
that  NT3  at this  concentration  does  not  significantly in- 
crease the expression of p75 mRNA in immature sympa- 
thetic neurons. 
Discussion 
Acquisition of NGF Responsiveness 
In agreement with previous studies of developing sympa- 
thetic  neurons  in  rodents  (Coughlin  and  Collins,  1985; 
DiCicco-Bloom and Black,  1988)  and  birds  (Rohrer and 
Thoenen, 1987; Ernsberger et al., 1989a;  Rodriguez-Tebar 
and Rohrer, 1991), we have shown that the survival of im- 
mature  sympathetic  neurons  is  initially  independent  of 
NGF. In E13 mouse SCG cultures, the majority of imma- 
ture neurons survive independently of NGF for at least 3 d 
and show no enhanced survival with NGF. NGF begins to 
enhance the survival of a small percentage of neurons in 
E14 cultures. The proportion of SCG neurons that depend 
on NGF for survival increases in  cultures  established  at 
later embryonic ages, reaching 90%  in E18 cultures.  Ac- 
quisition  of  the  NGF  survival  response  correlates  with 
c-los induction by NGF. With both developmental age and 
NGF concentration,  the  proportion  of neurons  that  sur- 
vive with NGF and express c-los  in response to NGF is 
very similar. Thus, by two criteria, survival and c-los  in- 
duction, the first SCG neurons start responding to NGF at 
or shortly after E14. 
Developmental Expression of trkA mRNA 
and p75 mRNA 
Using quantitative RT/PCR, we determined the levels of 
trkA mRNA and p75 mRNA in the developing SCGs. At 
E13, the levels of these mRNAs are very low, which is in 
accord with  the  unresponsiveness of cultured  SCG  neu- 
rons to NGF at this early stage of development. Between 
E14 and E15, there is a sixfold increase in the level of trkA 
mRNA, which is closely related to the onset of NGF re- 
sponsiveness in a proportion of the neurons in vitro at this 
stage. In marked contrast to the NGF-dependent sensory 
neurons of the developing mouse trigeminal ganglion, in 
which the levels of trkA mRNA and p75 mRNA are very 
similar and increase in parallel with the acquisition of the 
NGF survival response (Wyatt and Davies, 1993), the in- 
creases in  trkA  mRNA  and  p75  mRNA are  out of step 
with one another in the developing SCG. The level of trkA 
mRNA initially increases much more rapidly than that of 
p75 mRNA, so that by E17 the level of trkA mRNA is al- 
most sevenfold higher than that of p75 mRNA. However, 
from E17 onward the level of p75 mRNA increases more 
rapidly.  The  difference  between  trkA  mRNA  and  p75 
mRNA is only threefold  by birth  (Fig.  4)  and  less than 
twofold by the fourth postnatal day (data not shown). The 
relative levels of trkA mRNA and p75 mRNA in whole 
ganglia  are  likely  to  reflect  the  relative  levels  of  these 
mRNAs in individual SCG neurons because a similar ratio 
is observed between trkA mRNA and p75 mRNA in puri- 
fied neuronal preparations and whole ganglia at the same 
stage of development. Although it was not possible to use 
differential sedimentation to obtain purified neurons from 
SCGs before E16,  several studies  have shown that early 
sympathetic ganglia are composed mainly of cells express- 
ing  neuronal  markers  (Rohrer  and  Thoenen,  1987;  Di- 
Cicco-Bloom and Black,  1988;  Ernsberger et al.,  1989b). 
Thus, at stages before purified neurons can be obtained, 
the  relative  levels  of  trkA  mRNA  and  p75  mRNA  in 
whole ganglia are also likely to reflect the relative levels of 
these mRNAs in early sympathetic neurons. 
The  different  developmental  profiles  of trkA  mRNA 
and  p75  mRNA  expression  in  sensory  and  sympathetic 
neurons suggest an explanation for the age-related differ- 
ences in the effect of a null mutation in the p75 gene on 
the  NGF  survival  response  of sensory  and  sympathetic 
neurons.  Trigeminal sensory neurons  of p75 -/-  embryos 
are threefold less sensitive to NGF in the mid-concentra- 
tion  range than  are trigeminal  neurons  of wild-type em- 
bryos, whereas the NGF dose response of embryonic SCG 
neurons  is  unaffected  by  this  mutation  (Davies  et  al., 
1993b).  However,  by the  postnatal  period,  the  dose  re- 
sponse of p75-deficient SCG neurons has shifted to higher 
NGF concentrations  compared with wild-type SCG neu- 
rons (Lee et al., 1994).  Likewise, mutant NGF molecules 
that  have negligible  binding  to p75  but  bind TrkA  nor- 
mally are less active on embryonic trigeminal and postna- 
tal sympathetic neurons than are wild-type NGF, whereas 
mutant  and wild-type NGF molecules are equally active 
on  embryonic sympathetic neurons  (A.  Horton, J.  Win- 
slow, and A. M. Davies, unpublished data). Although we 
do not know the relationship between mRNA and protein 
levels for TrkA and p75 in developing sensory and sympa- 
thetic  neurons,  our present findings  suggest  that embry- 
onic sympathetic neurons  are unaffected by the p75 null 
mutation because these neurons normally express low lev- 
els  of p75  relative  to  TrkA.  Embryonic trigeminal  and 
postnatal sympathetic neurons are affected by the p75 mu- 
tation because they normally express relatively higher lev- 
els of p75 than embryonic sympathetic neurons. 
In situ hybridization (Birren et al., 1993)  and Northern 
blotting (DiCicco-Bloom et al., 1993) have shown that the 
expression of trkA mRNA increases markedly during em- 
bryonic  development  as  sympathetic  neurons  acquire  a 
survival response to NGF. More recently, Verdi and An- 
derson (1994) used RT/PCR to compare the levels of p75 
and trkA mRNAs in immature sympathetic neurons (neu- 
roblasts) and sympathetic ganglia with the levels of these 
mRNAs in  PC12  cells.  Although  these  authors  failed to 
detect  p75  and  trkA  mRNAs  in  neuroblasts  from early 
sympathetic ganglia when, as we have shown, the levels of 
these  mRNAs  are  similar, they found  that trkA  mRNA 
expression precedes p75 mRNA expression during devel- 
opment. The stages at which trkA mRNA and p75 mRNA 
where first detected in sympathetic neuroblasts/neurons of 
the rat embryo roughly correspond with the developmen- 
tal  stages  at  which  we  demonstrate  marked increases  in 
the  levels of expression  of these  mRNAs  in  the  mouse 
SCG. However, in contrast to our direct measurements of 
p75 and trkA mRNA levels, which show that the level of 
p75 mRNA approaches but does not exceed that of trkA 
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level of p75 mRNA is tenfold greater than that  of trkA 
mRNA by the first postnatal day. The reason for this dis- 
crepancy is most likely a result of differences in the meth- 
ods used to measure mRNA levels.  To control for varia- 
tions  in  PCR  reaction  conditions,  Verdi  and  Anderson 
used  a  synthetic internal  control DNA template  in each 
PCR  reaction  that  was  amplified  alongside  the  target 
cDNA templates (p75, trkA, and actin cDNAs). However, 
this control DNA was unrelated to the target cDNAs and 
was amplified by different primers to those used to am- 
plify the target cDNAs. Because amplification efficiency is 
greatly influenced  by the  lengths  and  sequences  of the 
templates  and PCR primers,  it is best to use an internal 
control template that is as similar as possible to the target 
cDNA template  and  to  amplify both control and  target 
templates with the same set of primers. For these reasons 
we  synthesized  separate  specific  control  DNAs for  p75 
and trkA that were identical  to the  target p75  and trkA 
cDNAs, except they were 3 or 4 bp longer (sufficient to re- 
solve target and control products on a PAGE gel). More- 
over, to control for differences in RT efficiency, these spe- 
cific  control templates  were  added  as  cRNA to  the  RT 
reactions. To normalize RNA levels between neuroblasts 
and  PC12  cells,  Verdi  and  Anderson  used  parallel  RT/ 
PCRs for actin mRNA, which could introduce additional 
problems, not only because these reactions were standard- 
ized with an unrelated control template, but because any 
developmental changes in actin mRNA expression would 
affect the comparison of p75 and trkA mRNA levels be- 
tween neuroblasts and PC12 cells.  Because we measured 
the absolute levels of p75 and trkA mRNAs using known 
amounts of specific cRNA control templates in each reac- 
tion, we did not need to resort to using another mRNA 
species to standardize our results to p75 and trkA mRNAs 
in some cell line.  Moreover, the accuracy of our quantita- 
tive RT/PCR assay has been verified by directly compar- 
ing the same samples assayed by this assay and by quanti- 
tative  Northern  blotting  using  specific RNA calibration 
and recovery standards (Wyatt and Davies, 1993). 
Regulation of trkA mRNA and p75 mRNA Expression 
In El3 SCG cultures, before any of the immature neurons 
have  become  NGF  dependent,  the  low  level  of  trkA 
mRNA expression  is  stably maintained  for at  least  3  d. 
Over the same period in vivo, the level of trkA mRNA in 
the ganglion increases almost 30-fold as many neurons ac- 
quire NGF dependence. Thus, when removed from their 
normal environment at a very early stage of their develop- 
ment, immature  sympathetic neurons do not display the 
normal  developmental  increase  in  trkA  mRNA expres- 
sion. This low level of trkA mRNA expression in imma- 
ture sympathetic neurons is also not affected by exposure 
to NGF. These findings are in accord with the observation 
that immature sympathetic neurons do not acquire NGF 
dependence  in  vitro  even if cultured  in  the  presence  of 
NGF (Leah and Kidson, 1983; Rodriguez-Tebar and Roh- 
rer, 1991). 
In E14 control cultures, the mean neuronal level of trkA 
mRNA is already ~10-fold higher after 24 h than the level 
in cultured E13 neurons and increases a further threefold 
between 24 and 48 h of incubation. This suggests that by 
E14, at least some immature neurons have become speci- 
fied to upregulate trkA mRNA expression in defined me- 
dium in the absence of added factors. Because the level of 
trkA mRNA does not increase in El3 cultures, this sug- 
gests that these immature neurons become specified to up- 
regulate trkA mRNA expression between El3 and El4 in 
vivo. The increase in trkA mRNA in El4 cultures does not 
depend on physical contact with other cells,  because it is 
observed in very low density cultures.  It is also indepen- 
dent of NGF, occurring to the same extent whether or not 
NGF is present in the culture medium. A similar phenom- 
enon is observed in developing trigeminal ganglion neu- 
rons in culture; at E12, when many neurons are acquiring 
NGF dependence, the level of trkA mRNA increases inde- 
pendently of the presence of NGF in the culture medium 
(Wyatt and Davies, 1993). 
In contrast to our demonstration that at least a propor- 
tion of immature neurons become specified by El4 to up- 
regulate trkA mRNA in defined medium in the absence of 
added factors, Verdi and Anderson (1994) did not observe 
increases in the level of trkA mRNA in cultures of E14.5 
or E15.5 rat immature sympathetic neurons (neuroblasts). 
Because trkA mRNA expression in these cultures was in- 
creased by NT3, it was concluded that NT3 may normally 
induce  trkA mRNA expression  in  these  cells.  However, 
the level of NT3 required to induce trkA mRNA expres- 
sion was two orders of magnitude higher than the level of 
NT3 that enhances the survival of these ceils  (Verdi and 
Anderson, 1994)  and is four orders of magnitude higher 
than  the  level  of NT3  that  promotes the  maturation  of 
early sensory neurons (Wright et al.,  1992). Whether such 
high  concentrations  of  NT3  are  available  to  immature 
sympathetic neurons under normal physiologic conditions 
is not known. 
Although we have shown that NGF does not affect trkA 
mRNA expression in developing sympathetic and sensory 
neurons  (Wyatt and Davies,  1993),  some studies  suggest 
that NGF increases trkA mRNA expression in vivo. How- 
ever, the reported effects are small and difficult to inter- 
pret because the data were obtained from grain counting 
in autoradiograms. Intraventricular infusion of NGF over 
a  2-wk period caused a  1.7-fold increase in grain density 
over forebrain cholinergic neurons in sections hybridized 
with a trkA probe (Holtzman et al.,  1992).  NGF infusion 
partially restored the level of trkA mRNA in adult DRG 
neurons after peripheral nerve section (Verge et al., 1992). 
However, the effect was small (grain counts were 48% of 
normal after nerve section alone and were elevated to only 
61%  of normal  after  nerve  section plus  NGF infusion), 
and NGF infusion did not affect the level of trkA mRNA 
expression in unlesioned DRG neurons.  Likewise, injec- 
tion of NGF into the anterior chamber of the eye of adult 
rats increased p75 mRNA but not trkA mRNA grain den- 
sity in the innervating SCG neurons (Miller et al., 1994). 
Although we  have  shown  that  the  developmental  in- 
crease in trkA mRNA is unaffected by NGF exposure, p75 
mRNA expression was increased by NGF from the earli- 
est stages studied.  Even in El3 cultures, when NGF nei- 
ther induces c-fos induction nor affects neuronal survival, 
the level of p75 mRNA was threefold higher in the pres- 
ence of NGF than in control cultures after 3 d of incuba- 
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pression was more marked; after 48 h  of incubation, the 
level of p75 mRNA was eightfold higher in the presence of 
NGF. These findings are consistent with other in vitro and 
in vivo studies showing that NGF increases the level of p75 
mRNA expression in embryonic trigeminal ganglion neu- 
rons (Wyatt and Davies, 1993), postnatal and adult sympa- 
thetic neurons (Miller et al., 1991,  1994), adult basal fore- 
brain cholinergic neurons (Cavicchioli et al., 1989; Higgins 
et al., 1989), and adult DRG neurons (Lindsay et al., 1990; 
Verge et al., 1992). 
Mature  sympathetic  neurons  and  adrenal  chromaffin 
cells are derived from cells that express markers character- 
istic  of both  lineages  (Anderson,  1993).  These  cells  are 
present in early sympathetic ganglia and the early adrenal 
medulla, and because they can give rise to either mature 
adrenal  chromaffin cells  or mature  sympathetic neurons 
under appropriate culture conditions, they have been termed 
sympathoadrenal  progenitor  cells  (Anderson,  1993).  As 
development  proceeds,  chromaffin-specific  markers  are 
lost  from cells  in  sympathetic ganglia,  whereas  neuron- 
specific markers are lost from cells in the adrenal medulla 
(Anderson  et  al.,  1991;  Carnahan  and  Patterson,  1991a, 
1991b). To provide a convenient source of large numbers 
of  sympathoadrenal  progenitor  cells  for  experimental 
studies, Birren and Anderson (1990) infected sympathoad- 
renal  progenitor  cells  isolated  from  E14.5  rat  adrenal 
glands with a v-rnyc-containing retrovirus to generate sev- 
eral cell lines. These MAH cells exhibit high-affinity nor- 
epinephrine  uptake,  express  tyrosine  hydroxylase  and 
neurofilament protein, and possess short processes (Birren 
and Anderson,  1990), but neither respond to NGF or ex- 
press  trkA  mRNA  by Northern  blotting  (Birren  et  al., 
1992),  although  very low  levels of trkA  mRNA  are  ex- 
pressed by RT/PCR (Verdi et al., 1994). However, in the 
presence  of  depolarizing  levels  of  KC1  (40  mM),  trkA 
mRNA became detectable by Northern blotting within 24 h 
and reached maximal levels within 3 d (Birren et al., 1992). 
In contrast, we have clearly shown that depolarizing levels 
of KC1 do not affect trkA mRNA expression in immature 
sympathetic neurons  before  they become dependent  on 
NGF for survival or as they acquire NGF dependence. In 
El3 SCG cultures, which are mainly composed of prolifer- 
ating,  NGF-independent,  immature sympathetic neurons 
that  are  analogous  to  the  sympathoadrenal  progenitor 
cells described in rat SCG at an equivalent stage of devel- 
opment, the level of trkA mRNA is unaffected by 40 mM 
KC1 up to 3 d in culture. The increase in trkA mRNA that 
takes place  in  El4  SCG  cultures,  as  some cells  acquire 
NGF dependence,  occurs irrespective of the presence of 
40 mM KC1 in the culture medium. There may be several 
reasons for the  apparent discrepancy between these two 
studies. First, the process of immortalizing sympathoadre- 
nal progenitor cells from the  early adrenal  medulla may 
have significantly changed  the  behavior of these cells so 
that MAH cells are not fully representative of their nor- 
mal counterparts.  Second,  MAH  cells  are  derived  from 
sympathoadrenal progenitor cells present in the early ad- 
renal  medulla.  Although  cells  expressing  neuronal  and 
chromaffin markers in the early adrenal medulla and early 
sympathetic  ganglia  are  generally  thought  of  as  being 
equivalent  (Anderson,  1993),  perhaps those  in the  early 
adrenal  medulla (which  normally only give rise to chro- 
maffin  cells)  respond  differently  to  depolarization  than 
their counterparts in early sympathetic ganglia. 
In contrast  to  the  induction  by retinoic  acid  of high- 
affinity NGF receptors and an NGF survival response in 
immature sympathetic neurons of chicken embryos (Rod- 
riguez-Tebar and Rohrer, 1991), we have shown that retin- 
oic acid over a broad range of concentrations (from 10  -9 
to 10 -6 M),  either alone or in combination with NGF, does 
not induce  the  expression of either trkA mRNA or p75 
mRNA in immature sympathetic neurons  of mouse  em- 
bryos. It is possible that this is a  result of species differ- 
ences in the effect of retinoic acid on neuronal develop- 
ment.  Retinoic  acid  does not,  for example, induce  NGF 
dependence in early trigeminal sensory neurons of mouse 
embryos (Paul and Davies, 1995). 
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